Colorectal cancer molecular diagnostics market seen reaching $4.15 billion by 2030
The colorectal cancer molecular diagnostics market is projected to grow from $3.02 billion in 2026 to $4.15 billion by 2030, according to The Business Research Company. Demand is rising as colorectal cancer cases increase, while labs and drug developers expand use of molecular testing, sequencing and companion diagnostics.
Why it matters: - Colorectal cancer diagnostics are becoming more important as healthcare systems push for earlier detection and more precise treatment selection. - The market is expanding alongside rising colorectal cancer incidence, which increases demand for tools that can identify mutations, biomarkers and treatment responses. - Growth in this segment also tracks broader adoption of precision oncology and minimally invasive testing.
What happened: - The Business Research Company published its Colorectal Cancer Molecular Diagnostics Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report estimates the market will rise from $2.78 billion in 2025 to $3.02 billion in 2026. - The report forecasts the market will reach $4.15 billion by 2030. - The report links that growth to an 8.5% CAGR in the historical period and an 8.3% CAGR in the forecast period. - Download a free sample of the report.
The details: - The report says market growth has been supported by higher colorectal cancer case counts, expanded diagnostic laboratory infrastructure, wider use of molecular testing, better awareness of early screening, and growing use of precision medicine. - The forecast period is expected to benefit from more investment in precision oncology, stronger demand for minimally invasive diagnostics, expanded genomic testing, greater use of AI in cancer diagnostics, and more focus on monitoring treatment response. - The report identifies rising use of molecular biomarker testing, PCR and sequencing technologies, personalized oncology diagnostics, companion diagnostics, and early detection strategies as key trends. - Colorectal cancer develops in the colon or rectum from abnormal cells in the inner lining of those organs. - Molecular diagnostics in colorectal cancer are used to detect genetic mutations, alterations and biomarkers that affect disease progression and treatment response. - In March 2023, the American Cancer Society projected about 153,020 colorectal cancer diagnoses in the United States and about 52,550 deaths. - The American Cancer Society also projected 19,550 cases and 3,750 deaths among people younger than 50 in the United States. - View the full report.
Between the lines: - North America was the largest regional market in 2025. - Asia Pacific is expected to be the fastest-growing region over the forecast period. - The regional scope also includes South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The market’s growth reflects a shift toward earlier, more targeted cancer care rather than broad, one-size-fits-all testing.
What's next: - The report points to continued demand for genomic testing, companion diagnostics and AI-enabled cancer tools through 2030. - Health systems and diagnostic providers are likely to keep investing in technologies that improve early detection and treatment monitoring. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, market hotspots infographics, and updated graphics and tables.
The bottom line: - Colorectal cancer molecular diagnostics is moving from a niche testing area to a larger precision-oncology market, with growth driven by rising disease burden and broader use of advanced molecular tools.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Middle East Culture Guide
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.